Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders

Ítems similars

• The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors
  per: Hurley, Carolyn Katovich, et al.
  Publicat: (2013)
• Evaluation of a Machine Learning-Based Prognostic Model for Unrelated Hematopoietic Cell Transplantation Donor Selection
  per: Buturovic, Ljubomir, et al.
  Publicat: (2018)
• MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study
  per: Askar, Medhat, et al.
  Publicat: (2016)
• Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders
  per: Horan, John, et al.
  Publicat: (2012)
• HLA-C Antigen mismatches are associated with worse outcomes in unrelated donor peripheral blood stem cell transplantation
  per: Woolfrey, Ann, et al.
  Publicat: (2010)